Laurus Labs Limited (LAURUSLABS.NS)
INR 571.5
(0.8%)
INR 571.5
(0.8%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 83.87 Billion INR | 9.49% |
| 2022 | 76.6 Billion INR | 9.94% |
| 2021 | 69.68 Billion INR | 21.17% |
| 2020 | 57.5 Billion INR | 53.34% |
| 2019 | 37.5 Billion INR | 12.58% |
| 2018 | 33.31 Billion INR | 10.42% |
| 2017 | 30.16 Billion INR | 13.69% |
| 2016 | 26.53 Billion INR | 15.21% |
| 2015 | 23.03 Billion INR | 24.98% |
| 2014 | 18.42 Billion INR | 44.73% |
| 2013 | 12.73 Billion INR | 80.98% |
| 2012 | 7.03 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 87.29 Billion INR | 0.0% |
| 2023 FY | 83.87 Billion INR | 9.49% |
| 2023 Q4 | 83.87 Billion INR | 0.0% |
| 2023 Q2 | 80.57 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 76.6 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 76.6 Billion INR | 9.94% |
| 2022 Q2 | 80.55 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 69.68 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 63.62 Billion INR | 0.0% |
| 2021 FY | 69.68 Billion INR | 21.17% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 57.5 Billion INR | 53.34% |
| 2020 Q4 | 57.5 Billion INR | 0.0% |
| 2020 Q2 | 42.51 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q2 | 36.16 Billion INR | 0.0% |
| 2019 FY | 37.5 Billion INR | 12.58% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 37.5 Billion INR | 0.0% |
| 2018 Q4 | 33.31 Billion INR | 0.0% |
| 2018 FY | 33.31 Billion INR | 10.42% |
| 2018 Q2 | 32.73 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 FY | 30.16 Billion INR | 13.69% |
| 2017 Q2 | 29.56 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 30.16 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 26.53 Billion INR | 0.0% |
| 2016 FY | 26.53 Billion INR | 15.21% |
| 2016 Q2 | 24.92 Billion INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2015 FY | 23.03 Billion INR | 24.98% |
| 2014 FY | 18.42 Billion INR | 44.73% |
| 2013 FY | 12.73 Billion INR | 80.98% |
| 2012 FY | 7.03 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Sigachi Industries Limited | 6.94 Billion INR | -1108.233% |
| Ind-Swift Limited | 6.54 Billion INR | -1181.497% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -996.161% |
| Sakar Healthcare Limited | 3.88 Billion INR | -2057.94% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 81.392% |
| Innova Captab Limited | 13.2 Billion INR | -534.957% |
| Divi's Laboratories Limited | 154.7 Billion INR | 45.785% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -677.997% |
| Morepen Laboratories Limited | 12.93 Billion INR | -548.546% |
| Mankind Pharma Limited | 119.63 Billion INR | 29.893% |
| Sequent Scientific Limited | 15.4 Billion INR | -444.477% |
| Wanbury Limited | 3.43 Billion INR | -2341.688% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -282.785% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -194.239% |
| Alembic Limited | 23.28 Billion INR | -260.148% |
| Hikal Limited | 24.87 Billion INR | -237.216% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | -30.121% |
| Neuland Laboratories Limited | 18.32 Billion INR | -357.667% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -109.984% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 41.589% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -273.687% |
| Themis Medicare Limited | 5.66 Billion INR | -1380.718% |
| RPG Life Sciences Limited | 5.12 Billion INR | -1535.313% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 71.357% |
| Lupin Limited | 239.97 Billion INR | 65.05% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -2186.1% |
| Wockhardt Limited | 76.49 Billion INR | -9.649% |
| Vaishali Pharma Limited | 799.55 Million INR | -10389.596% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -224.814% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -3763.602% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 27.376% |
| FDC Limited | 24.68 Billion INR | -239.819% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 78.357% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -3393.699% |
| Eris Lifesciences Limited | 70.48 Billion INR | -18.985% |
| Venus Remedies Limited | 6.26 Billion INR | -1238.007% |
| ZIM Laboratories Limited | 4.46 Billion INR | -1777.039% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -590.934% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -8154.049% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -210.932% |
| Shilpa Medicare Limited | 30.93 Billion INR | -171.144% |
| Albert David Limited | 4.97 Billion INR | -1584.171% |
| Ajanta Pharma Limited | 46.38 Billion INR | -80.818% |
| Hester Biosciences Limited | 6.62 Billion INR | -1166.259% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -272.081% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -257.412% |
| Gufic Biosciences Limited | 10.92 Billion INR | -667.662% |
| Windlas Biotech Limited | 6.26 Billion INR | -1239.34% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -955.822% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -2649.917% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -2415.423% |
| Granules India Limited | 55.2 Billion INR | -51.912% |
| Aarti Drugs Limited | 24.32 Billion INR | -244.81% |
| Bal Pharma Limited | 3.2 Billion INR | -2517.765% |
| Alkem Laboratories Limited | 155.74 Billion INR | 46.15% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 90.186% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -1097.65% |
| Medicamen Biotech Limited | 2.94 Billion INR | -2747.671% |
| Unichem Laboratories Limited | 31.69 Billion INR | -164.63% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -5579.13% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -17713.401% |
| Valiant Laboratories Limited | 3.42 Billion INR | -2347.429% |
| Orchid Pharma Limited | 15.53 Billion INR | -439.75% |
| Medico Remedies Limited | 961.95 Million INR | -8618.752% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -619.851% |
| Ipca Laboratories Limited | 111.01 Billion INR | 24.45% |
| Brooks Laboratories Limited | 904.45 Million INR | -9173.031% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -1972.592% |
| Piramal Enterprises Limited | 826.05 Billion INR | 89.847% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 44.313% |
| NATCO Pharma Limited | 69.06 Billion INR | -21.44% |
| Suven Life Sciences Limited | 2.84 Billion INR | -2843.823% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -4607.195% |
| Strides Pharma Science Limited | 58.39 Billion INR | -43.62% |
| Indoco Remedies Limited | 21.44 Billion INR | -291.053% |
| Alpa Laboratories Limited | 1.82 Billion INR | -4492.57% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -5459.158% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -1528.423% |